Isomorphic Labs is in talks to raise about $5 billion at a $50 billion valuation
Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .
If the round is completed, Isomorphic will have substantial resources to move SI-designed drugs from research into clinical trials.
According to Bloomberg, the Alphabet company spun out of Google DeepMind is negotiating new funding to develop drugs using SI. The publication's sources put the potential round at about $5 billion and Isomorphic Labs' valuation at about $50 billion. The deal has not closed, and its terms could change.
Sources 1